Senior Field Access Director, Endocrinology (Remote)

Corcept Therapeutics; United States; On-site; USD 212,000 - 300,000; Full time

Job summary

Corcept Therapeutics seeks a strategic Market Access FRM Leader to guide national field access initiatives for Korlym and Relacorilant. You will shape strategy, manage the FRM team, and partner with Sales, HUB, Trade, and Compliance to remove payer barriers.

This senior role emphasizes leadership, cross-functional collaboration, and data-driven performance with up to 50% travel and a focus on measurable access outcomes across regions.

Qualifications

• Proven success leading a national or large regional FRM/Access team.
• Deep knowledge of payer policy, reimbursement processes, HUB services, and patient support programs.
• Strong leadership with a track record of building high‑performing teams.
• 12+ years in pharma/biotech with 5+ years in reimbursement/market access and 5+ years in direct leadership.

Responsibilities

• Lead and mentor the national FRM team, providing strategic direction and performance feedback.
• Define and drive national field access strategy for Korlym and Relacorilant.
• Establish and monitor KPIs, productivity metrics, and business objectives.
• Oversee field deployment, territory alignments, and resource allocation.
• Design, implement, and oversee the FRM team’s MBO plan and incentive structure.
• Serve as liaison between FRM and Sales, HUB, Patient Services, Trade, Market Access, Legal, and Compliance.

Skills

National team leadership

Payer policy knowledge

Cross-functional collaboration

Strategic thinking

Communication skills

Analytical mindset

Education

Bachelor’s degree

Advanced degree preferred

Job description

Corcept Therapeutics seeks a strategic Market Access FRM Leader to guide national field access initiatives for Korlym and Relacorilant. You will shape strategy, manage the FRM team, and partner with Sales, HUB, Trade, and Compliance to remove payer barriers.

This senior role emphasizes leadership, cross-functional collaboration, and data-driven performance with up to 50% travel and a focus on measurable access outcomes across regions.